Getinge AB (publ) (OTCPK:GNGBF) Q1 2025 Earnings Conference Call April 22, 2025 7:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - Chief Financial Officer Conference Call Participants Rickard Anderkrans - Handelsbanken Mattias Vadsten - SEB Erik Cassel - Danske Bank Markets Kristofer Liljeberg-Svensson - Carnegie Investment Bank Sten Gustafsson - ABG Sundal Collier Aisyah Noor - Morgan Stanley David Adlington - JPMorgan Operator Welcome to the Getinge Q1 Report 2025. [Operator Instructions].
Getinge AB (OTCPK:GNGBF) Q4 2024 Results Conference Call January 28, 2025 4:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Rickard Anderkrans - Handelsbanken Erik Cassel - Danske Bank Aisyah Noor - MS Mattias Vadsten - SEB Kristofer Liljeberg - Carnegie Investment Bank Patrik Ling - DNB Markets Operator Welcome to the Getinge Q4 Report 2024. [Operator Instructions] Now I will hand the conference over to speakers CEO, Mattias Perjos; and CFO, Agneta Palmer.
Getinge AB (OTCPK:GNGBF) Q3 2024 Earnings Conference Call October 18, 2024 4:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Erik Cassel - Danske Bank Mattias Vadsten - SEB Kristofer Liljeberg - Carnegie Investment Bank David Johansson - Nordea Markets Aisyah Noor - Morgan Stanley Oliver Reinberg - Kepler Cheuvreux David Adlington - JPMorgan Sten Gustafsson - ABG Sundal Collier Rickard Anderkrans - Handelsbanken Aisyah Noor - Morgan Stanley Kristofer Liljeberg - Carnegie Investment Bank Operator Welcome to the Getinge Q3 Report 2023. [Operator Instructions].
![]() GNGBF In 10 months Estimated | Annual | $0.48 Per Share |
![]() GNGBF 1 month ago Paid | Annual | $0.48 Per Share |
![]() GNGBF 23 Apr 2024 Paid | Annual | $0 Per Share |
![]() GNGBF 27 Apr 2023 Paid | Annual | $0 Per Share |
![]() GNGBF 27 Apr 2022 Paid | Annual | $0 Per Share |
![]() GNGBF 21 Apr 2021 Paid | Annual | $0 Per Share |
18 Jul 2025 (40 Days) Date | | - Cons. EPS | - EPS |
21 Apr 2025 Date | | - Cons. EPS | - EPS |
28 Jan 2025 Date | | - Cons. EPS | 0.23 EPS |
18 Oct 2024 Date | | - Cons. EPS | 0 EPS |
18 Jul 2024 Date | | - Cons. EPS | 0.18 EPS |
![]() GNGBF In 10 months Estimated | Annual | $0.48 Per Share |
![]() GNGBF 1 month ago Paid | Annual | $0.48 Per Share |
![]() GNGBF 23 Apr 2024 Paid | Annual | $0 Per Share |
![]() GNGBF 27 Apr 2023 Paid | Annual | $0 Per Share |
![]() GNGBF 27 Apr 2022 Paid | Annual | $0 Per Share |
![]() GNGBF 21 Apr 2021 Paid | Annual | $0 Per Share |
18 Jul 2025 (40 Days) Date | | - Cons. EPS | - EPS |
21 Apr 2025 Date | | - Cons. EPS | - EPS |
28 Jan 2025 Date | | - Cons. EPS | 0.23 EPS |
18 Oct 2024 Date | | - Cons. EPS | 0 EPS |
18 Jul 2024 Date | | - Cons. EPS | 0.18 EPS |
Medical - Devices Industry | Healthcare Sector | Mr. Mattias Perjos M.Sc. CEO | OTC PINK Exchange | SE0000202624 ISIN |
SE Country | 11,827 Employees | 24 Apr 2025 Last Dividend | - Last Split | - IPO Date |
Getinge AB (publ) is a global provider of products and solutions targeted at improving efficiencies and outcomes in operating rooms, intensive-care units, sterilization departments, and more. Established in 1904 and based in Gothenburg, Sweden, the company enriches healthcare facilities worldwide through its three operative segments: Acute Care Therapies, Life Science, and Surgical Workflows. It is dedicated to offering a wide range of medical technologies and services, catering to the critical areas of patient care and scientific processes. Getinge stands out for its comprehensive product portfolio that addresses complex healthcare challenges, aiming for innovation in patient care and clinical results. The company extends its reach through an extensive network of sales companies and partners across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions, ensuring its solutions are accessible globally.
These are life-saving therapies for patients in critical conditions, offering support for heart and lung functions.
Comprehensive patient monitoring and management systems designed for the intensive care environment, improving patient flow and care efficiency.
Essential tools and technologies for cardiac surgery, enhancing surgical outcomes and patient recovery.
State-of-the-art solutions for the operating room, facilitating better coordination, safety, and efficiency during surgical procedures.
Comprehensive infection control solutions that ensure the cleanliness and sterility of medical devices and environments, backed by advanced connectivity for seamless operations.
Advanced solutions supporting the life science industry in drug development and manufacturing processes with a focus on sterility and containment.
Equipment and systems designed for research labs and bioprocessing facilities, ensuring safe handling of materials and sterility for bioprocessing applications.